A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma

Yusheng Chen(Nanjing Drum Tower Hospital), He Cheng(Shanghai Medical College of Fudan University), Yunzhen Qian(Shanghai Medical College of Fudan University), Chen Liu(Hubei Provincial Women and Children's Hospital), Yu Liu(Sichuan University), Xianjun Yu(Fudan University Shanghai Cancer Center), Ruijie Wang(Fudan University), Xuan Zou(Fudan University Shanghai Cancer Center), Xuan Lin(Beijing Technology and Business University), Xu Wang(Jiangsu University of Science and Technology)
Research Square
July 5, 2022
10.21203/rs.3.rs-1719611/v2
Cited by 0

Related Papers

FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis
|Cell Research|2014|1.2k
Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China
|New England Journal of Medicine|2009|603
The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease
|Lipids in Health and Disease|2017|298
LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer
|Cell Death and Disease|2015|205
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
|Nature Genetics|2011|198